Clinical Report: Assessment of Complications in Non-Transfusion-Dependent Thalassemia

Overview

This study evaluates the clinical complications and treatment patterns in patients with non-transfusion-dependent thalassemia (NTDT) compared to matched controls in the U.S. Findings indicate that NTDT patients experience significantly higher rates of serious complications, including malignancy and cardiovascular disease.

Background

Non-transfusion-dependent thalassemia (NTDT) can lead to severe clinical complications that adversely affect patient quality of life. Previous studies have primarily focused on NTDT in Europe and Asia, leaving a gap in understanding its impact in the U.S. This study aims to fill that gap by analyzing real-world data on NTDT patients.

Data Highlights

Key Findings

• Patients with NTDT had a significantly higher incidence of malignancy (17.4% vs. 7.1%) compared to controls.
• Cardiovascular disease was observed in 15.4% of NTDT patients versus 7.8% of controls.
• 6.7% of NTDT patients experienced liver disease, compared to only 0.5% of controls.
• Gallstones were present in 6.7% of NTDT patients, while only 2.1% of controls were affected.
• 18.8% of NTDT patients required at least one blood transfusion during the study period.
• Only 4.0% of NTDT patients received oral chelators for iron overload management.

Clinical Implications

The findings underscore the need for heightened awareness and monitoring of complications in NTDT patients. Clinicians should consider early intervention strategies to manage complications and improve patient outcomes.

Conclusion

This study highlights the significant clinical burden faced by NTDT patients in the U.S., necessitating further research and development of effective treatment options to mitigate complications.

References

1. Thalassaemia International Federation, NCBI Bookshelf, 2023 -- Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia
2. Bone Marrow Transplantation — Acute Vascular Complications Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
3. Clinical Rheumatology — Assessment of Comorbid Conditions in Individuals with Ankylosing Spondylitis Utilizing a Comprehensive US Claims Database
4. Intensive Care Medicine — Physiological determinants and the red blood cells transfusion decision-making process in non-bleeding critically ill patients: a comprehensive narrative review
5. Bone Marrow Transplantation — The 50th Annual Conference of the European Society for Blood and Marrow Transplantation: Physician Presentations (O009-O154)
6. Guidelines for the Management of α-Thalassaemia
7. Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE)
8. INTRODUCTION - Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia - NCBI Bookshelf